Lv4
470 积分 2024-09-23 加入
Using AChR antibody titres to predict treatment responses in myasthenia gravis
22天前
已完结
Antibodies against the main immunogenic region of the acetylcholine receptor correlate with disease severity in myasthenia gravis
22天前
已完结
Myasthenia gravis — autoantibody characteristics and their implications for therapy
1个月前
已完结
Subgroup stratification and outcome in recently diagnosed generalized myasthenia gravis
1个月前
已完结
Endovascular treatment versus standard medical treatment for vertebrobasilar artery occlusion (BEST): an open-label, randomised controlled trial
1个月前
已完结
Advances and ongoing research in the treatment of autoimmune neuromuscular junction disorders
1个月前
已完结
Reply to the Letter to the Editor in response to “Role of autoantibody levels as biomarkers in the management of patients with myasthenia gravis: A systematic review and expert appraisal”
1个月前
已完结
Autoantibody levels as biomarkers of disease activity in the management of myasthenia gravis
1个月前
已完结
皖公网安备34019202002308
